AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8340879 — intervention group
Group type: EXPERIMENTAL
Intervention: Poker Chip Tool
Number of subjects: 70
Study 3552295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (35 mg acetylsalicylate per day for 7 days)
Number of subjects: 7
Study 3552295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 31883278 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame
Number of subjects: 65
Study 31883278 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 65
Study 31883278 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 65
Study 30050947 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineralized solvent‐dehydrated bone allograft (MCBA)
Number of subjects: 6
Study 30050947 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze‐dried mineralized bone allograft (FDBA)
Number of subjects: 6
Study 30050947 — intervention group
Group type: EXPERIMENTAL
Intervention: Anorganic bovine bone (ABB)
Number of subjects: 6
Study 30050947 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine‐derived bone (EB)
Number of subjects: 6
Study 30050947 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic micro‐macroporous biphasic calcium‐phosphate block (HA‐β‐TCP 30/70)
Number of subjects: 6
Study 30050947 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioapatite‐collagen (BC)
Number of subjects: 6
Study 26269281 — intervention group
Group type: EXPERIMENTAL
Intervention: Chevrolet MyLink system (one voice command)
Number of subjects: 80
Study 26269281 — intervention group
Group type: COMPARATOR
Intervention: Volvo Sensus system (multiple commands)
Number of subjects: 80
Study 24389518 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg·kg(‐1) body mass tyrosine (TYR)
Number of subjects: 7
Study 24389518 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric quantity of whey powder (PLA)
Number of subjects: 7
Study 22454410 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Atrial Septum (LAS) pacing
Number of subjects: 57
Study 22454410 — intervention group
Group type: COMPARATOR
Intervention: Right Atrial Appendage (RAA) pacing
Number of subjects: 57
Study 20012918 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mg alendronate once weekly (n = 23)
Number of subjects: 46
Study 20012918 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 23)
Number of subjects: 46
Study 18686766 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (control) - no blood contamination
Number of subjects: 75
Study 18686766 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 - blood contaminated, rinsed with water
Number of subjects: 75
Study 18686766 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 - blood contaminated, air-dried
Number of subjects: 75
Study 18686766 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4 - blood contaminated, rinsed and air-dried
Number of subjects: 75
Study 18686766 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 5 - blood contaminated, no post-contamination treatment
Number of subjects: 75
Study 15851341 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-ms ascending ramp waveform (RAMP)
Number of subjects: 63
Study 15851341 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-ms ascending ramp waveform (RAMP)
Number of subjects: 63
Study 15851341 — intervention group
Group type: COMPARATOR
Intervention: Biphasic truncated exponential waveform (BTE)
Number of subjects: 63
Study 12649655 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace with minimal tension
Number of subjects: 15
Study 12649655 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace with 2.5 kg force tension
Number of subjects: 15
Study 12649655 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace with 5 kg force tension
Number of subjects: 15
Study 12649655 — intervention group
Group type: COMPARATOR
Intervention: No brace
Number of subjects: 15
Study 9704793 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal delivery
Number of subjects: 60
Study 9704793 — intervention group
Group type: COMPARATOR
Intervention: Cesarean section
Number of subjects: 60
Study 8549578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense daily isometric and isokinetic leg exercise
Number of subjects: 12
Study 8549578 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 12
Study 2725453 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 3.75 mg
Number of subjects: 10
Study 2725453 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 10
Study 2725453 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31991755 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship intervention
Number of subjects: 180
Study 31991755 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-parenting intervention
Number of subjects: 180
Study 31991755 — intervention group
Group type: COMPARATOR
Intervention: Information control
Number of subjects: 180
Study 29855386 — intervention group
Group type: EXPERIMENTAL
Intervention: Early motion and directed exercise (EMADE) intervention consisting of a non-weight-bearing progressive home exercise programme, complemented with manual therapy and education.
Number of subjects: 144
Study 29855386 — intervention group
Group type: COMPARATOR
Intervention: Usual care consisting of immobilisation in a non-weight-bearing below-knee cast for 6 weeks.
Number of subjects: 144
Study 29855386 — intervention group
Group type: EXPERIMENTAL
Intervention: Early motion and directed exercise (EMADE) intervention
Number of subjects: 144
Study 29855386 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 144
Study 28628064 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 44
Study 28628064 — intervention group
Group type: COMPARATOR
Intervention: MICT
Number of subjects: 44
Study 28628064 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT and MICT
Number of subjects: 44
Study 26691355 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload (10 ml/kg crystalloid before induction)
Number of subjects: 60
Study 26691355 — intervention group
Group type: COMPARATOR
Intervention: Coload (10 ml/kg crystalloid at the time of spinal anesthesia)
Number of subjects: 60
Study 23402713 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% milk (44 kcal/100 ml)
Number of subjects: 29
Study 23402713 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice (44 kcal/100 ml)
Number of subjects: 29
Study 23402713 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular cola (44 kcal/100 ml)
Number of subjects: 29
Study 23402713 — intervention group
Group type: COMPARATOR
Intervention: Diet cola (0 kcal)
Number of subjects: 29
Study 23402713 — intervention group
Group type: COMPARATOR
Intervention: Water (0 kcal)
Number of subjects: 29
Study 21138519 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed lanthanum 1000 mg 3 times daily
Number of subjects: 11
Study 21138519 — intervention group
Group type: COMPARATOR
Intervention: Chewed lanthanum 1000 mg 3 times daily
Number of subjects: 11
Study 19483246 — intervention group
Group type: EXPERIMENTAL
Intervention: Health information leaflets
Number of subjects: 398
Study 19483246 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorthiazide information sheets
Number of subjects: 398
Study 17302877 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestradiol (2 x 0.1 mg/day patches) for days 5-16
Number of subjects: 8
Study 17302877 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Oestradiol + Progesterone (200 mg/day for days 13-16)
Number of subjects: 8
Study 17302877 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist
Number of subjects: 8
Study 15533381 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU hCG
Number of subjects: 0
Study 15533381 — intervention group
Group type: COMPARATOR
Intervention: 20,000 IU hCG
Number of subjects: 0
Study 11125410 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 0.05% mometasone furoate
Number of subjects: 40
Study 11125410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9767545 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor (trandolapril) + calcium antagonist (verapamil)
Number of subjects: 37
Study 9767545 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitor (trandolapril)
Number of subjects: 37
Study 9767545 — intervention group
Group type: COMPARATOR
Intervention: Calcium antagonist (verapamil)
Number of subjects: 37
Study 8162670 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (500 mg orally)
Number of subjects: 20
Study 8162670 — intervention group
Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 20
Study 3492487 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 100 mg
Number of subjects: 75
Study 3492487 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 250 mg
Number of subjects: 75
Study 3492487 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole 960 mg
Number of subjects: 75
Study 30172098 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial invasive strategy (cardiac catheterization and optimal revascularization plus optimal medical therapy)
Number of subjects: 777
Study 30172098 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy (optimal medical therapy alone)
Number of subjects: 777
Study 30172098 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial invasive strategy
Number of subjects: 777
Study 26558626 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3, 0.45, or 0.6 mg) administered as a single intravenous bolus 30 min before the end of surgery
Number of subjects: 50
Study 26558626 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3, 0.45, or 0.6 mg)
Number of subjects: 50
Study 24149923 — intervention group
Group type: EXPERIMENTAL
Intervention: TVT‐O (inside‐out transobturator tape)
Number of subjects: 94
Study 24149923 — intervention group
Group type: EXPERIMENTAL
Intervention: TVT‐S (tension-free vaginal tape SECUR)
Number of subjects: 94
Study 24149923 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TVT‐O and TVT‐S)
Number of subjects: 94
Study 22198793 — intervention group
Group type: COMPARATOR
Intervention: Decolonization of the index case alone (index group)
Number of subjects: 183
Study 22198793 — intervention group
Group type: EXPERIMENTAL
Intervention: Decolonization of all household members (household group)
Number of subjects: 183
Study 22198793 — intervention group
Group type: COMPARATOR
Intervention: Household group compared to index group
Number of subjects: 183
Study 20478446 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination labial plus lingual infiltration of 4% articaine with 1:100,000 epinephrine
Number of subjects: 82
Study 20478446 — intervention group
Group type: COMPARATOR
Intervention: Labial infiltration of 4% articaine with 1:100,000 epinephrine
Number of subjects: 82
Study 18328410 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution
Number of subjects: 8
Study 18328410 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat (0.1%) milk
Number of subjects: 8
Study 18328410 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat (0.1%) milk with added glucose
Number of subjects: 8
Study 18328410 — intervention group
Group type: COMPARATOR
Intervention: Plain water
Number of subjects: 8
Study 17666672 — intervention group
Group type: EXPERIMENTAL
Intervention: Group interpersonal psychotherapy
Number of subjects: 314
Study 17666672 — intervention group
Group type: EXPERIMENTAL
Intervention: Group interpersonal psychotherapy (girls)
Number of subjects: 314
Study 17666672 — intervention group
Group type: EXPERIMENTAL
Intervention: Group interpersonal psychotherapy (boys)
Number of subjects: 314
Study 17666672 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative play
Number of subjects: 314
Study 17666672 — intervention group
Group type: COMPARATOR
Intervention: Wait-control group
Number of subjects: 314
Study 15015143 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 13
Study 15015143 — intervention group
Group type: EXPERIMENTAL
Intervention: White wine
Number of subjects: 13
Study 15015143 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic beverage (control)
Number of subjects: 13
Study 11128913 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM/P-15 grafts
Number of subjects: 33
Study 11128913 — intervention group
Group type: COMPARATOR
Intervention: ABM
Number of subjects: 33
Study 11128913 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM/P-15
Number of subjects: 33
Study 9054788 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 416
Study 9054788 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 416
Study 9054788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study 7691911 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (low concentration: 3.9 +/- 1.0 mg/liter)
Number of subjects: 11
Study 7691911 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (medium concentration: 8.2 +/- 1.8 mg/liter)
Number of subjects: 11
Study 7691911 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (high concentration: 13.2 +/- 2.3 mg/liter)
Number of subjects: 11
Study 7691911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 3101537 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 15-1788 (0.6-1.0 mg)
Number of subjects: 40
Study 3101537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31519270 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management forms of meditation
Number of subjects: 0
Study 31519270 — intervention group
Group type: COMPARATOR
Intervention: Cognitive distraction meditation
Number of subjects: 0
Study 28423234 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI with RDN
Number of subjects: 76
Study 28423234 — intervention group
Group type: COMPARATOR
Intervention: PVI-only
Number of subjects: 76
Study 25854014 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive group (acupuncture based on ziwuliuzhu + prozac)
Number of subjects: 93
Study 25854014 — intervention group
Group type: COMPARATOR
Intervention: Ziwuliuzhu group (acupuncture based on ziwuliuzhu)
Number of subjects: 93
Study 25854014 — intervention group
Group type: COMPARATOR
Intervention: Prozac group (oral administration of prozac)
Number of subjects: 93
Study 22608267 — intervention group
Group type: EXPERIMENTAL
Intervention: Social gain-frame message
Number of subjects: 108
Study 22608267 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical loss-frame message
Number of subjects: 108
Study 22608267 — intervention group
Group type: COMPARATOR
Intervention: Social loss-frame message
Number of subjects: 108
Study 22608267 — intervention group
Group type: COMPARATOR
Intervention: Physical gain-frame message
Number of subjects: 108
Study 21042828 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 200 mg/day
Number of subjects: 16
Study 21042828 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study 19272581 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM) course
Number of subjects: 43
Study 19272581 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR) course
Number of subjects: 43
Study 19272581 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MM and PMR
Number of subjects: 43
Study 16731542 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed appliances subsequent to rapid maxillary expansion (RME) and facemask therapy
Number of subjects: 29
Study 16731542 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 29
Study 16731542 — intervention group
Group type: COMPARATOR
Intervention: Class I controls
Number of subjects: 29
Study 15318541 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone used in the introduction of anaesthesia
Number of subjects: 361
Study 11258645 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral creatine supplements (4 x 5 g per day)
Number of subjects: 0
Study 11258645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9290397 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff occlusion (30 seconds, 1.5, 2.5, 3.5, 4.5, and 8 minutes)
Number of subjects: 6
Study 9290397 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) doses (10, 20, 50, 100, 200, and 400 micrograms)
Number of subjects: 6
Study 8322582 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 0.5 g daily + Paracetamol 4 g daily
Number of subjects: 18
Study 8322582 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 1.0 g daily + Paracetamol 4 g daily
Number of subjects: 18
Study 8322582 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 1.5 g daily
Number of subjects: 18
Study 8322582 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 0.5 g daily
Number of subjects: 18
Study 8322582 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 1.0 g daily
Number of subjects: 18
Study 2426830 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem infusion (0.5 to 2.0 mcg/kg/min i.v.)
Number of subjects: 40
Study 2426830 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diltiazem)
Number of subjects: 40
Study 31655513 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA CTrach
Number of subjects: 60
Study 31655513 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Fastrach
Number of subjects: 60
Study 31655513 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 60
Study 28097630 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased social support at 12-months
Number of subjects: 991
Study 28097630 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and need variables
Number of subjects: 991
Study 26123343 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic insertion of a biliary stent
Number of subjects: 43
Study 24004766 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill desk with exercise counseling and accelerometer feedback for 12 weeks
Number of subjects: 20
Study 24004766 — intervention group
Group type: COMPARATOR
Intervention: No treadmill desk (control period)
Number of subjects: 20
Study 22310410 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior approach
Number of subjects: 36
Study 22310410 — intervention group
Group type: COMPARATOR
Intervention: Posterior approach
Number of subjects: 36
Study 19901841 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physician information program and feedback system (IG)
Number of subjects: 19254
Study 19901841 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 19254
Study 17932996 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-based multifactorial fall prevention programme (intervention group, IG)
Number of subjects: 591
Study 17932996 — intervention group
Group type: COMPARATOR
Intervention: One-time counselling group (control group, CG)
Number of subjects: 591
Study 16044037 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based treatment principles
Number of subjects: 0
Study 16044037 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic review process
Number of subjects: 0
Study 16044037 — intervention group
Group type: EXPERIMENTAL
Intervention: Research designs in dental practice
Number of subjects: 0
Study 11955536 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg) administered intravenously at weeks 0, 2, and 6
Number of subjects: 70
Study 11955536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 11955536 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 70
Study 9536943 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine suppositories (Pentasa) 1 g three times a week
Number of subjects: 95
Study 9536943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 9536943 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine suppositories (Pentasa) 1 g/day for relapse
Number of subjects: 95
Study 9536943 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 95
Study 8585370 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed high frequency electric field
Number of subjects: 120
Study 8585370 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous current
Number of subjects: 120
Study 8585370 — intervention group
Group type: COMPARATOR
Intervention: Imitation of therapy
Number of subjects: 120
Study 2693026 — intervention group
Group type: EXPERIMENTAL
Intervention: R1 (50 mg/d, p. o; total dose: 18.25 g/yr/case)
Number of subjects: 89
Study 2693026 — intervention group
Group type: EXPERIMENTAL
Intervention: R2 (20 mg/d, p. o; total dose: 3.6 g/6mos/case)
Number of subjects: 89
Study 2693026 — intervention group
Group type: COMPARATOR
Intervention: Control group (riboflavin 50 mg/d, p. o.)
Number of subjects: 89
Study 558950 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 10
Study 558950 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ, 12.5 mg)
Number of subjects: 10
Study 558950 — intervention group
Group type: COMPARATOR
Intervention: Amobarbital (100 mg)
Number of subjects: 10
Study 558950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31113242 — intervention group
Group type: EXPERIMENTAL
Intervention: In-situ group fixed with suture button technique
Number of subjects: 12
Study 31113242 — intervention group
Group type: COMPARATOR
Intervention: Malreduced group rigidly held with a 3.5-mm screw
Number of subjects: 12
Study 31113242 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic arthroscopy by 3 fellowship-trained foot and ankle orthopaedic surgeons
Number of subjects: 12
Study 31113242 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic arthroscopy measurements
Number of subjects: 12
Study 31045231 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD‐tDCS
Number of subjects: 36
Study 31045231 — intervention group
Group type: COMPARATOR
Intervention: Sham HD‐tDCS
Number of subjects: 36
Study 28825853 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-platinum-based chemotherapy (NPBC) followed by platinum-based chemotherapy (PBC) at subsequent relapse (experimental arm)
Number of subjects: 215
Study 28825853 — intervention group
Group type: COMPARATOR
Intervention: Standard reverse treatment sequence (control arm)
Number of subjects: 215